Jianmin Pharmaceutical Group Co.,Ltd. (SHSE: 600976)
Health Care · Pharmaceuticals · CN
CN¥27.51
+2.42% today · -31.7% 1Y
Jianmin Pharmaceutical Group Co.,Ltd. (SHSE: 600976) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $630.03M and employs 2,257 people.
Over the last twelve months the share price has lost 31.7%, trading between 24.68 and 40.73.
Tweenvest scores Jianmin Pharmaceutical Group Co.,Ltd. across four factors: quality 72/100, value 85/100, growth 56/100, dividend 61/100. Its strongest factor is value.
600976 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $630.03M
- Revenue (TTM)
- $467.62M
- P/E
- 13.22
- EPS
- 2.08
- Dividend yield
- 3.27%
- Beta (5Y)
- 0.07
- 52-week high
- CN¥40.73
- 52-week low
- CN¥24.68
- Avg volume (3M)
- —
- Shares outstanding
- 153.40M
- Employees
- 2,257
- Next earnings
- —
About Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co.,Ltd. operates within China, focusing on the production and distribution of traditional Chinese medicines. The company's product line features pediatric pharmaceuticals, prominently sold under its Jianmin and Longmu brand names. In addition to these offerings, Jianmin provides a range of over-the-counter (OTC) drugs, various medical and health products, and consultation services. The firm's main corporate offices are located in Wuhan, China.
- ISIN
- CNE000001HB7
- Founded
- 1637
- Listed since
- Apr 19, 2004
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| LanZhou Foci Pharmaceutical Co.,Ltd.SZSE: 002644 | $639.65M | CN¥8.39 | +1.57% |
| Chimin Health Management Co., Ltd.SHSE: 603222 | $636.24M | CN¥8.30 | +2.85% |
| Zhejiang Wecome Pharmaceutical Company LimitedSZSE: 300878 | $634.11M | CN¥29.90 | -0.86% |
| Shandong Wohua Pharmaceutical Co., Ltd.SZSE: 002107 | $633.39M | CN¥7.35 | +3.67% |
| Newland Pharmaceutical Co., Ltd.SZSE: 301277 | $629.84M | CN¥10.76 | +2.77% |
| TTY Biopharm Company LimitedTPEX: 4105 | $629.11M | NT$80.90 | +2.53% |
| Senores Pharmaceuticals LimitedNSEI: SENORES | $628.13M | Rs1,320.00 | -2.19% |
| Wuhan Hvsen Biotechnology Co.,Ltd.SZSE: 300871 | $625.65M | CN¥20.91 | -0.90% |
Figures last refreshed Oct 11, 2026.